STALLION THERAPEUTICS, INC.

Basic Information

741 S. LIMESTONE STREET
LEXINGTON, KY, 40536

Company Profile

n/a

Additional Details

Field Value
DUNS: 791384774
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Novel Neuroprotectants for TBI

    Amount: $128,100.00

    DESCRIPTION (provided by applicant): There are no FDA approved pharmacological therapies for the acute treatment of traumatic brain injury (TBI) that mitigate damaging neurological effects. However, t ...

    STTR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government